Citigroup upgraded Puma Biotechnology from Neutral to Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/28/2021 | $11.00 | Neutral → Buy | Citigroup |
| 9/28/2021 | Neutral → Buy | Citigroup | |
| 8/6/2021 | $13.00 → $6.00 | Sector Perform | RBC Capital |
| 8/6/2021 | $9.00 → $8.00 | Sell | Goldman Sachs |
Citigroup upgraded Puma Biotech. from Neutral to Buy and set a new price target of $11.00
Citigroup upgraded Puma Biotechnology from Neutral to Buy
RBC Capital reiterated coverage of Puma Biotechnology with a rating of Sector Perform and set a new price target of $6.00 from $13.00 previously